🔎 Trials Near Me

Home › Tumor sa Utak at Spinal Cord › Washington

Pag-aaral pangklinika para sa Tumor sa Utak at Spinal Cord sa Washington

6 pag-aaral para sa Tumor sa Utak at Spinal Cord ang naghahanap ng mga kalahok sa mga site sa Washington.

Mga Lungsod sa Washington

Opisyal na teksto ng pag-aaral (English)

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

  • Northwest Medical Specialties, Tacoma
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06047379

Project: Every Child for Younger Patients With Cancer

  • Seattle Children's Hospital, Seattle
  • Providence Sacred Heart Medical Center and Children's Hospital, Spokane
  • Mary Bridge Children's Hospital and Health Center, Tacoma
  • at 1 pa
Nagre-recruitObservasyonal na pag-aaral
Hanggang edad 25 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT02402244

Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).

  • Seattle Children's Hospital, Seattle
Nagre-recruitPhase 2
Edad 1 hanggang 26 · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT07680439

DALY II USA/ MB-CART2019.1 for DLBCL

  • Fred Hutchinson Cancer Center, Seattle
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT04792489

Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors

  • Seattle Children's Hospital, Seattle
Nagre-recruitPhase 1
Edad 1 hanggang 26 · Lahat ng kasarian · Na-update Abr 13, 2026 · NCT04185038

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Seattle
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.